Pfizer (PFE) trades at about 95% of its 52-week high. The business that has to justify that price, the medicines it has ...
Income investors shouldn't be too worried about the pharma giant cutting its dividend.
Pfizer has a huge 6% yield and a payout ratio well over 100%, yet the company is still maintaining the dividend.
The drugmaker has targeted air-traffic control fees in a dispute with Poland and Romania.
Pfizer has raised its dividend every year for over a decade, then something changed. Before you count on that 6% yield, find ...
Pfizer's 6% dividend yield is enticing, but AbbVie's dividend growth is superior.
Pfizer (NYSE:PFE) has signed a co-development and license deal with Medicus Pharma for an early clinical-stage ...
Doses of Moderna’s mFlusiva are available at CVS. Walgreens expects to begin receiving shipments of the vaccine any day now.
Pfizer Inc. (NYSE: PFE) and Valneva SE (NASDAQ: VALN) reported on August 14 that the European Medicines Agency has validated ...
The US Treasury Department is drafting rules to allow most pharma licensing deals with China while restricting pathogen and ...
Pfizer's 6.4% yield and cheap valuation support a $35 target; Chevron's Hess synergies and Microsoft power deal back $250 by 2027. AbbVie's Skyrizi and Rinvoq each grew over 20% in Q2, driving ...
The Motley Fool on MSN
Why Pfizer Stock Was so Healthy in August
The beaten-down pharmaceutical stock was revived after it posted an estimates-beating quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results